Skip to content
healthcare.dev

daptomycin

NDC 14335-120, daptomycin, injection, powder, lyophilized, for suspension, from Hainan Poly Pharm., Co., Ltd..

Product NDC
14335-120
Status
Listed
Labeler
Hainan Poly Pharm., Co., Ltd.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA215890
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/14335-120 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DAPTOMYCIN500 mg/20mL

Pharmacologic classes

Lipopeptide Antibacterial [EPC]; Lipopeptides [CS]

Package NDCNDC-11Package
14335-120-011433501200120 mL in 1 VIAL, SINGLE-DOSE (14335-120-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6ec53f7e-9a5f-4b24-84e9-c94325750e32

Use it

Look up 14335-120 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/14335-120 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 14335-120. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.